Cancer Research and Treatment10.4143/crt.2018.0842019511158-168Impact of Pulmonary Tuberculosis on the EGFR Mutational Status and Clinical Outcome in Patients with Lung AdenocarcinomaIn Kyoung Hwang, Seung Sook Paik, Seung Hyeun Lee,,
The Journal of Thoracic and Cardiovascular Surgery10.1016/j.jtcvs.2017.07.053201715451766-1767EGFR mutational status in lung adenocarcinoma: Staging implications or continuous evolution?Winifred M. Lo, R. Taylor Ripley,
Journal of Thoracic Oncology10.1016/j.jtho.2019.08.179020191410S831P2.14-05 EGFR Mutation Status and Prognostic Impact in Patients with Surgically Resected Lung AdenocarcinomaY. Tokunaga, Y. Kita, T. Okamoto,
Annals of Oncology10.1093/annonc/mdx729201728x183Analysis of EGFR mutation status in blood and CSF in lung adenocarcinoma patients with EGFR mutation and CNS metastasis by ddPCRY. Sen, Q. Wang,,
Clinical Lung Cancer10.1016/j.cllc.2020.10.0192020Progression patterns of metastatic lung adenocarcinoma patients with EGFR mutationShinichiro Okauchi, Katsunori Kagohashi, Toshihiro Shiozawa, Kunihiko Miyazaki, Hiroaki Satoh,
Lung Cancer10.1016/s0169-5002(13)70016-3201379S616 EGFR mutational analysis for adenocarcinoma of the lung; outcome by mutation since the introduction of routine molecular testing in one cancer networkA.F.C. Okines, P. Brulinski, D. Gonzalez de Castro, R. Shah,
Radiology and Oncology10.2478/raon-2014-00162014482173-183Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survivalKarmen Stanic, Matjaz Zwitter, Nina Turnsek Hitij, Izidor Kern, Aleksander Sadikov, Tanja Cufer,
Tuberculosis and Respiratory Diseases10.4046/trd.2018.0004201982162Factors that Predict Clinical Benefit of EGFR TKI Therapy in Patients with EGFR Wild-Type Lung AdenocarcinomaSeo Yun Kim, Jae Kyung Myung, Hye-Ryoun Kim, Im Il Na, Jae Soo Koh, Hee Jong Baek, Cheol Hyeon Kim,,
Clinical Lung Cancer10.1016/j.cllc.2017.01.0092017183316-323.e1Non–Small-cell Lung Cancer Patients With Adenocarcinoma Morphology Have a Better Outcome Compared With Patients Diagnosed With Non–Small-cell Lung Cancer Favor AdenocarcinomaIris Shiran, Eyal Heller, Shlomit Jessel, Iris Kamer, Inbal Daniel-Meshulam, Rossie Navon, Damien Urban, Amir Onn, Jair Bar,
Lung Cancer10.1016/j.lungcan.2018.03.0132018119120-126Impacts of EGFR-mutation status and EGFR-TKI on the efficacy of stereotactic radiosurgery for brain metastases from non-small cell lung adenocarcinoma: A retrospective analysis of 133 consecutive patientsShoji Yomo, Kyota Oda,